PGM1 and metabolic myopathy: Thus far, it has been estimated that over 50% of PGM1-deficient patients present with metabolic myopathy ranging from mild to severe exercise intolerance, muscle weakness, and fatigability, hypotonia, and rhabdomyolysis.